• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

部分容积校正提高了18F-氟代贝他吡正电子发射断层扫描检测早期淀粉样变性的灵敏度。

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis.

作者信息

Teipel Stefan J, Dyrba Martin, Vergallo Andrea, Lista Simone, Habert Marie Odile, Potier Marie-Claude, Lamari Foudil, Dubois Bruno, Hampel Harald, Grothe Michel J

机构信息

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.

Department of Psychosomatic Medicine, University Medicine Rostock, Rostock, Germany.

出版信息

Front Aging Neurosci. 2021 Dec 22;13:748198. doi: 10.3389/fnagi.2021.748198. eCollection 2021.

DOI:10.3389/fnagi.2021.748198
PMID:35002673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8729321/
Abstract

To test whether correcting for unspecific signal from the cerebral white matter increases the sensitivity of amyloid-PET for early stages of cerebral amyloidosis. We analyzed 18F-Florbetapir-PET and cerebrospinal fluid (CSF) Aβ42 data from 600 older individuals enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI), including people with normal cognition, mild cognitive impairment (MCI), and Alzheimer's disease (AD) dementia. We determined whether three compartmental partial volume correction (PVC-3), explicitly modeling signal spill-in from white matter, significantly improved the association of CSF Aβ42 levels with global 18F-Florbetapir-PET values compared with standard processing without PVC (non-PVC) and a widely used two-compartmental PVC method (PVC-2). In additional voxel-wise analyses, we determined the sensitivity of PVC-3 compared with non-PVC and PVC-2 for detecting early regional amyloid build-up as modeled by decreasing CSF Aβ42 levels. For replication, we included an independent sample of 43 older individuals with subjective memory complaints from the INveStIGation of AlzHeimer's PredicTors cohort (INSIGHT-preAD study). In the ADNI sample, PVC-3 18F-Florbetapir-PET values normalized to whole cerebellum signal showed significantly stronger associations with CSF Aβ42 levels than non-PVC or PVC-2, particularly in the lower range of amyloid levels. These effects were replicated in the INSIGHT-preAD sample. PVC-3 18F-Florbetapir-PET data detected regional amyloid build-up already at higher (less abnormal) CSF Aβ42 levels than non-PVC or PVC-2 data. A PVC approach that explicitly models unspecific white matter binding improves the sensitivity of amyloid-PET for identifying the earliest stages of cerebral amyloid pathology which has implications for future primary prevention trials.

摘要

为了测试校正来自脑白质的非特异性信号是否会提高淀粉样蛋白PET对脑淀粉样变性早期阶段的敏感性。我们分析了来自阿尔茨海默病神经影像学倡议(ADNI)的600名老年人的18F-氟代贝他吡PET和脑脊液(CSF)Aβ42数据,包括认知正常、轻度认知障碍(MCI)和阿尔茨海默病(AD)痴呆患者。我们确定,与未进行部分容积校正(非PVC)的标准处理和广泛使用的两室部分容积校正方法(PVC-2)相比,明确模拟白质信号溢出的三室部分容积校正(PVC-3)是否能显著改善CSF Aβ42水平与整体18F-氟代贝他吡PET值之间的相关性。在额外的体素级分析中,我们确定了PVC-3与非PVC和PVC-2相比,在检测由CSF Aβ42水平降低所模拟的早期区域淀粉样蛋白积聚方面的敏感性。为了进行重复验证,我们纳入了来自阿尔茨海默病预测指标队列(INSIGHT-preAD研究)的43名有主观记忆主诉的老年人的独立样本。在ADNI样本中,归一化为全小脑信号的PVC-3 18F-氟代贝他吡PET值与CSF Aβ42水平的相关性显著强于非PVC或PVC-2,特别是在较低的淀粉样蛋白水平范围内。这些效应在INSIGHT-preAD样本中得到了重复验证。与非PVC或PVC-2数据相比,PVC-3 18F-氟代贝他吡PET数据在CSF Aβ42水平较高(异常程度较轻)时就能检测到区域淀粉样蛋白积聚。一种明确模拟非特异性白质结合的部分容积校正方法提高了淀粉样蛋白PET识别脑淀粉样病变最早阶段的敏感性,这对未来的一级预防试验具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/61ec9625edae/fnagi-13-748198-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/504e3e080a9b/fnagi-13-748198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/7175a89e1fdc/fnagi-13-748198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/67e9279d3816/fnagi-13-748198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/3601c42887af/fnagi-13-748198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/05a442efeed6/fnagi-13-748198-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/61ec9625edae/fnagi-13-748198-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/504e3e080a9b/fnagi-13-748198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/7175a89e1fdc/fnagi-13-748198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/67e9279d3816/fnagi-13-748198-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/3601c42887af/fnagi-13-748198-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/05a442efeed6/fnagi-13-748198-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac6/8729321/61ec9625edae/fnagi-13-748198-g006.jpg

相似文献

1
Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis.部分容积校正提高了18F-氟代贝他吡正电子发射断层扫描检测早期淀粉样变性的灵敏度。
Front Aging Neurosci. 2021 Dec 22;13:748198. doi: 10.3389/fnagi.2021.748198. eCollection 2021.
2
Quantitative F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.认知正常的老年人、轻度认知障碍患者及阿尔茨海默病患者的定量F-AV1451脑tau蛋白PET成像
Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019.
3
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.脑脊液分析比正电子发射断层扫描更早检测到脑淀粉样β蛋白的积累。
Brain. 2016 Apr;139(Pt 4):1226-36. doi: 10.1093/brain/aww015. Epub 2016 Mar 2.
4
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
5
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.认知和神经影像学特征以及阿尔茨海默病风险个体的脑β-淀粉样蛋白(INSIGHT-preAD):一项纵向观察性研究。
Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2. Epub 2018 Feb 27.
6
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.使用淀粉样蛋白正电子发射断层扫描对β-淀粉样蛋白病理学进行分期
JAMA Neurol. 2019 Nov 1;76(11):1319-1329. doi: 10.1001/jamaneurol.2019.2214.
7
18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.18F-Flortaucipir PET 与阿尔茨海默病导致的轻度认知障碍患者的脑脊液、认知和神经影像学的相关性。
J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.
8
Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.基于临床的脑脊液生物标志物与氟代脱氧葡萄糖 PET 对痴呆症的诊断验证。
J Alzheimers Dis. 2018;61(1):135-143. doi: 10.3233/JAD-170753.
9
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.阿尔茨海默病谱中血液磷酸化 tau181 的时间进程。
Brain. 2021 Feb 12;144(1):325-339. doi: 10.1093/brain/awaa399.
10
Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.脑淀粉样血管病和阿尔茨海默病中氟脱氧葡萄糖-PET 的区域性分布:一项 PET 研究。
J Alzheimers Dis. 2020;73(4):1607-1614. doi: 10.3233/JAD-190625.

引用本文的文献

1
International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease.国际核医学关于淀粉样蛋白正电子发射断层扫描在阿尔茨海默病临床应用的共识
Phenomics. 2022 Aug 26;3(4):375-389. doi: 10.1007/s43657-022-00068-9. eCollection 2023 Aug.
2
Software compatibility analysis for quantitative measures of [F]flutemetamol amyloid PET burden in mild cognitive impairment.轻度认知障碍中[F]氟代甲磺酸淀粉样蛋白PET负荷定量测量的软件兼容性分析。
EJNMMI Res. 2023 May 24;13(1):48. doi: 10.1186/s13550-023-00994-3.
3
Quantification of amyloid PET for future clinical use: a state-of-the-art review.

本文引用的文献

1
Longitudinal validity of PET-based staging of regional amyloid deposition.基于正电子发射断层扫描的局部淀粉样沉积分期的纵向有效性。
Hum Brain Mapp. 2020 Oct 15;41(15):4219-4231. doi: 10.1002/hbm.25121. Epub 2020 Jul 10.
2
Spill-in counts in the quantification of F-florbetapir on Aβ-negative subjects: the effect of including white matter in the reference region.Aβ阴性受试者中F-氟代硼替佐米定量时的溢出计数:参考区域纳入白质的影响
EJNMMI Phys. 2019 Dec 19;6(1):27. doi: 10.1186/s40658-019-0258-7.
3
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging.
用于未来临床应用的淀粉样 PET 的量化:最新综述。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.
淀粉样蛋白病理的时空顺序和 PET 成像的机会。
J Nucl Med. 2020 Feb;61(2):166-171. doi: 10.2967/jnumed.119.235879. Epub 2019 Dec 13.
4
A pitfall of white matter reference regions used in [F] florbetapir PET: a consideration of kinetics.[F]氟比洛芬 PET 中使用的白质参考区域的一个缺陷:对动力学的考虑。
Ann Nucl Med. 2019 Nov;33(11):848-854. doi: 10.1007/s12149-019-01397-y. Epub 2019 Aug 27.
5
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.使用淀粉样蛋白正电子发射断层扫描对β-淀粉样蛋白病理学进行分期
JAMA Neurol. 2019 Nov 1;76(11):1319-1329. doi: 10.1001/jamaneurol.2019.2214.
6
CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.脑脊液生物标志物与淀粉样 PET 检测在 MCI 队列中的一致性和诊断准确性。
Acta Neurol Belg. 2019 Sep;119(3):445-452. doi: 10.1007/s13760-019-01112-8. Epub 2019 Mar 7.
7
Estimation of amyloid distribution by [F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.[F]氟替美莫 PET 对淀粉样蛋白分布的评估可预测淀粉样 β 蛋白沉积的神经病理学阶段。
Acta Neuropathol. 2018 Oct;136(4):557-567. doi: 10.1007/s00401-018-1897-9. Epub 2018 Aug 19.
8
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.使用 florbetapir 标准化摄取比值对 Centiloid 量表进行淀粉样蛋白定量的标准化。
Alzheimers Dement. 2018 Dec;14(12):1565-1571. doi: 10.1016/j.jalz.2018.06.1353. Epub 2018 Jul 11.
9
White Matter Reference Region in PET Studies of C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition.正电子发射断层扫描研究中 C-Pittsburgh 化合物 B 摄取的脑白质参考区域:年龄和淀粉样蛋白-β沉积的影响。
J Nucl Med. 2018 Oct;59(10):1583-1589. doi: 10.2967/jnumed.117.204271. Epub 2018 Apr 19.
10
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.